Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Behm

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
Lancet (London, England)|January 22, 1991
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyG K Rivera, S C Raimondi, M L Hancock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group studyM A Weiner, B Leventhal, M L Brecher, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Leukemia|October 3, 2002
Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experienceJ E Rubnitz, S C Raimondi, A R Halbert, et al.
Blood|June 15, 1995
Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reactionJ R Downing, S A Shurtleff, M Zielenska, et al.
Medical and Pediatric Oncology|October 23, 1997
Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experienceG Karayalcin, F G Behm, P W Gieser, et al.
Blood|December 1, 1987
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyA J Carroll, S C Raimondi, D L Williams, et al.
Blood|January 1, 1990
Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemiaC H Pui, F G Behm, B Singh, et al.
Blood|April 1, 1988
Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemiaC H Pui, S H Ip, S Iflah, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
Lancet (London, England)|January 22, 1991
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyG K Rivera, S C Raimondi, M L Hancock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group studyM A Weiner, B Leventhal, M L Brecher, et al.
Leukemia|December 1, 1995
TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosisS A Shurtleff, A Buijs, F G Behm, et al.
Leukemia|October 3, 2002
Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experienceJ E Rubnitz, S C Raimondi, A R Halbert, et al.
Blood|June 15, 1995
Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reactionJ R Downing, S A Shurtleff, M Zielenska, et al.
Medical and Pediatric Oncology|October 23, 1997
Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experienceG Karayalcin, F G Behm, P W Gieser, et al.
Blood|December 1, 1987
tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group StudyA J Carroll, S C Raimondi, D L Williams, et al.
Blood|January 1, 1990
Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemiaC H Pui, F G Behm, B Singh, et al.
Blood|April 1, 1988
Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemiaC H Pui, S H Ip, S Iflah, et al.
Pageof 17